Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression
Go back to Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression| (NASDAQ: JAGX) | Delayed: 2.81 -0.23 (7.57%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.04 | 52 Week High | $4.60 | |||
| Open | $3.00 | 52 Week Low | $0.81 | |||
| Day High | $3.00 | P/E | N/A | |||
| Day Low | $2.70 | EPS | $0.00 | |||
| Volume | 48,568 | |||||

